Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Samuel AbbouKelly S KlegaJunko TsujiMohammad TanhaemamiDavid C HallDonald A BarkauskasMark D KrailoCarrie CibulskisAnwesha NagAaron R ThornerSamuel PollockAlma ImamovicJack F ShernSteven G DuBoisRajkumar VenkatramaniDouglas S HawkinsBrian D CromptonPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Our study demonstrates that baseline ctDNA detection is feasible and is prognostic in IR RMS.